[1] HIV/AIDS, Reproductive Health Matters. 2005;13(25):187–93 https://doi.org/10.1016/S0968-8080(05)25177-7.
[2] Jackson BS, Pretorius E. Pathological clotting and deep vein thrombosis in patients with HIV. InSeminars in thrombosis and hemostasis 2019;45(2):132-40. https://doi.org/ 10.1055/s-0038-1676374.
[3] Zon LI, Groopman JE. Hematologic manifestations of the human immune deficiency virus (HIV). InSeminars in hematology 1988;25(3):208-18.
[4] Nonnemacher MR, Quiterio S, Allen AG, Mele AR, Pirrone V, Wigdahl B. Myelomonocytic cell lines in modeling HIV-1 infection of the bone marrow. Biology of Myelomonocytic Cells. InTech. 2017;10:129-62. http://dx.doi.org/10.5772/67596.
[5] Mathews SE, Srivastava D, Yadav RB, Sharma A. Association of hematological profile of human immunodeficiency virus-positive patients with clinicoimmunologic stages of the disease. Journal of laboratory physicians. 2013;5(01):34-7. https://doi.org/10.4103/0974-2727.115929.
[6] Vaillant AA, Gulick PG. HIV Disease Current Practice. 2020.
[7] Parinitha SS, Kulkarni MH. Haematological changes in HIV infection with correlation to CD4 cell count. The Australasian medical journal. 2012;5(3):157-62. https:doi.org/ 10.4066/AMJ.20121008.
[8] Sharika S, Jayapal T, Stephenson J, DS AR, Rajasekharan C. The clinical profile of patients diagnosed as having HIV infection with special reference to Joint manifestations and its correlation with CD4 count. International Journal of Health and Clinical Research. 2021;4(8):249-53.
[9] Srinivasa Rao B, Jagannadham R, Manojna B. Relation between clinical profile, CD4 count and total lymphocyte count in HIV infected persons. Journal of Evidence Based Medicine and Healthcare. 2019; 6(52), 3225-9. https:doi.org/10.18410/jebmh/2019/677.
[10] Gange SJ, Lau B, Phair J, Riddler SA, Detels R, Margolick JB. Rapid declines in total lymphocyte count and hemoglobin in HIV infection begin at CD4 lymphocyte counts that justify antiretroviral therapy. Aids. 2003;17(1):119-21.
[11] Abebe M, Alemseged F. Hematologic abormalities among children on Haart, in Jimma university specialized hospital, southwestern ethiopia. Ethiopian Journal of Health Sciences. 2009;19(2):83-9. https:doi.org/10.4314/ejhs.v19i2.69420.
[12] Kibaru EG, Nduati R, Wamalwa D, Kariuki N. Impact of highly active antiretroviral therapy on hematological indices among HIV-1 infected children at Kenyatta National Hospital-Kenya: retrospective study. AIDS research and therapy. 2015;12(1):1-8. https://doi.org/10.1186/s12981-015-0069-4.
[13] Thulasi RR, Manimaran D, Hemanathan G, Afroz T, Sagar R. Hematological abnormalities in HIV infected individuals in correlation to CD4 counts and ART status. Asian Journal of Medical Sciences. 2016;7(4):14-8. https://doi.org/10.3126/ajms.v7i4.14033.
[14] Duguma N, Tesfaye Kiya G, Adissu Maleko W, Bimerew LG. Hematological parameters abnormalities and associated factors in HIV-positive adults before and after highly active antiretroviral treatment in Goba Referral Hospital, southeast Ethiopia: a cross-sectional study. SAGE open medicine. 2021.
https://doi.org/10.1177/20503121211020175.